ロード中...
PCSK9 and carbohydrate metabolism: A double-edged sword
Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a paramount role in the degradation of low-density lipoprotein (LDL) receptors (LDLR) on the hepatic cells surface and subsequently affects LDL particles catabolism and LDL cholesterol (LDL-c) levels. The anti-PCSK9 monoclonal antibodies le...
保存先:
| 出版年: | World J Diabetes |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Inc
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5507827/ https://ncbi.nlm.nih.gov/pubmed/28751953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v8.i7.311 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|